Package 0078-1420-15

Brand: vanrafia

Generic: atrasentan
NDC Package

Package Facts

Identity

Package NDC 0078-1420-15
Digits Only 0078142015
Product NDC 0078-1420
Description

30 TABLET, FILM COATED in 1 BOTTLE (0078-1420-15)

Marketing

Marketing Status
Marketed Since 2025-04-02
Brand vanrafia
Generic atrasentan
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "af74a97e-160b-4335-9bc5-97a29e721d1b", "openfda": {"unii": ["E4G31X93ZA"], "rxcui": ["2710454", "2710460"], "spl_set_id": ["9a7e7f85-bfd0-44a0-beda-3bcfa8215c64"], "manufacturer_name": ["Novartis Pharmaceuticals Corporation"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (0078-1420-15)", "package_ndc": "0078-1420-15", "marketing_start_date": "20250402"}], "brand_name": "VANRAFIA", "product_id": "0078-1420_af74a97e-160b-4335-9bc5-97a29e721d1b", "dosage_form": "TABLET, FILM COATED", "product_ndc": "0078-1420", "generic_name": "atrasentan", "labeler_name": "Novartis Pharmaceuticals Corporation", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "VANRAFIA", "active_ingredients": [{"name": "ATRASENTAN HYDROCHLORIDE", "strength": ".75 mg/1"}], "application_number": "NDA219208", "marketing_category": "NDA", "marketing_start_date": "20250402", "listing_expiration_date": "20261231"}